Word: panels
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...uproar in the medical community was immediate. In a reversal of standard practice that bewildered physicians and patients around the nation, an independent government panel this week abandoned its long-standing recommendation that healthy women over age 40 get a breast-cancer screen once every year or two years. The U.S. Preventive Services Task Force began advising women instead to delay regular screening until age 50, and even then, to get tested only every other year. (Read "U.S. Panel Recommends Delaying Regular Mammograms Until...
...Members of the government panel expected a backlash, but the magnitude of the public response was a revelation. "It's surprising to me not only the amount of reaction but the emotionality and the degree to which this has caused upset," says Dr. Diana Petitti, vice chair of the task force...
...member panel found that yearly mammograms unquestionably reduced the risk of dying from breast cancer 15% in women under 50. But when weighed against the risks of screening - false positives, additional biopsies and patient anxiety - the relative benefit was too small to recommend screening in younger women. That conclusion has incensed some oncologists. "They are saying that we should take mammography away from women in their 40s because ... these factors outweigh the value of lives saved," says Dr. David Dershaw at Memorial Sloan-Kettering Cancer Center. (See pictures from an X-ray studio...
...Supreme Court Justices' choosing to hear this case has to do with the nuances of the decision at a lower court. After the U.S. patent office denied their patent in 2006, the Bilski-Warsaw duo took their appeal to the Court of Appeals for the Federal Circuit. The panel of 12 judges heard the case, and came to the conclusion that the patent office was justified in its dismissal...
...recommendations are based on analyses of two sets of data. In the first analysis the task force examined the results of existing trials on mammography, much of which had not changed since the panel last considered the issue in 2002; this time, however, the data was re-evaluated taking into account the current, and better, understanding of the potential harms associated with mammography - information that shifts the balance of risks versus benefits of screening...